Rendering

Component: (Network and Table)
Network
103 - Statement - Consolidated Balance Sheets
(http://www.abiomed.com/taxonomy/role/StatementOfFinancialPositionClassified)
TableStatement [Table]
Slicers (applies to each fact value in each table cell)
Statement [Line Items]Period [Axis]
2012-03-31
2011-03-31
2010-03-31
2009-03-31
ASSETS
 
 
 
 
Current assets:
 
 
 
 
Cash and cash equivalents
5,990,000  
5,831,000  
4,788,000  
1,785,000  
Short-term marketable securities
71,233,000  
54,481,000  
 
 
Accounts receivable, net
20,458,000  
15,376,000  
 
 
Inventories
11,142,000  
7,505,000  
 
 
Prepaid expenses and other current assets
1,716,000  
1,544,000  
 
 
Total current assets
110,539,000  
 
84,737,000  
 
 
 
 
 
Property and equipment, net
6,378,000  
6,273,000  
 
 
Intangible assets, net
115,000  
1,632,000  
 
 
Goodwill
36,846,000  
38,946,000  
 
 
Other long-term assets
33,000  
 
 
 
Total assets
153,911,000  
 
131,588,000  
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
 
 
Current liabilities:
 
 
 
 
Accounts payable
6,910,000  
6,283,000  
 
 
Accrued expenses
12,480,000  
14,078,000  
 
 
Deferred revenue
3,025,000  
1,982,000  
 
 
Total current liabilities
22,415,000  
 
22,343,000  
 
 
 
 
 
Long-term deferred tax liability
4,799,000  
4,010,000  
 
 
Other long-term liabilities
400,000  
492,000  
 
 
Total liabilities
27,614,000  
 
26,845,000  
 
 
 
 
 
Commitments and contingencies (Note 10)
xsi:nil 
xsi:nil 
 
 
Stockholders' equity:
 
 
 
 
Class B Preferred Stock, $.01 par value Authorized-1,000,000 shares; Issued and outstanding-none
xsi:nil 
xsi:nil 
 
 
Common stock, $.01 par value Authorized-100,000,000 shares; Issued-39,323,708 shares at March 31, 2012 and 37,756,719 shares at March 31, 2011; Outstanding-39,272,754 shares at March 31, 2012 and 37,705,765 shares at March 31, 2011
393,000  
377,000  
 
 
Additional paid in capital
401,771,000  
379,218,000  
 
 
Accumulated deficit
(273,275,000) 
(274,770,000) 
 
 
Treasury stock at cost-50,954 shares
(827,000) 
(827,000) 
 
 
Accumulated other comprehensive (loss) income
(1,765,000) 
745,000  
 
 
Total stockholders' equity
126,297,000  
 
104,743,000  
 
107,956,000  
 
115,983,000  
 
Total liabilities and stockholders' equity
153,911,000  
 
131,588,000